AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $49,000 | +8.9% | 83,869 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $45,000 | -40.0% | 83,869 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $75,000 | -7.4% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | +5.2% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $77,000 | -27.4% | 83,869 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $106,000 | +5.0% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $101,000 | -29.4% | 83,869 | +1.9% | 0.00% | -25.0% |
| Q2 2015 | $143,000 | +11.7% | 82,292 | -6.7% | 0.00% | 0.0% |
| Q1 2015 | $128,000 | +73.0% | 88,219 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $74,000 | -32.7% | 88,219 | -11.2% | 0.00% | -25.0% |
| Q3 2014 | $110,000 | -43.6% | 99,319 | -6.9% | 0.00% | -42.9% |
| Q2 2014 | $195,000 | +21.9% | 106,701 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $160,000 | -20.0% | 106,701 | -2.2% | 0.01% | -30.0% |
| Q4 2013 | $200,000 | -28.1% | 109,101 | -2.0% | 0.01% | -52.4% |
| Q2 2013 | $278,000 | – | 111,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |